Skip to main content

Main menu

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC

User menu

Search

  • Advanced search
JPN
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC
JPN

Advanced Search

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow JPN on Twitter
Psychopharmacology for the Clinician

Repetitive transcranial magnetic stimulation for depression

Robert G. Cooke
J Psychiatry Neurosci September 01, 2003 28 (5) 400;
Robert G. Cooke
Depression Clinic, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, Ont.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

A 56-year-old woman with recurrent major depressive disorder refractory to medication had a good response to an acute course of right unilateral electroconvulsive therapy (ECT) but experienced significant cognitive effects and refused maintenance ECT. Is she a good candidate for repetitive transcranial magnetic stimulation?

Repetitive transcranial magnetic stimulation (rTMS) involves the application of a rapid train of magnetic pulses directly to the head of a patient, inducing electrical activity in underlying cortical neurons, which, depending on the stimulation frequency, results in transient activation or inhibition of targeted brain regions. rTMS offers the promise of a new, non-invasive, non-pharmacologic intervention for psychiatric illness.

For depressed patients, rTMS involving both high frequency stimulation of the left prefrontal cortex and low frequency stimulation of the right prefrontal cortex, has been evaluated for clinical effectiveness, but the results of numerous open studies and controlled comparisons with sham rTMS, medication and ECT have been mixed. Both positive and negative results have been reported (Aarre et al, Nord J Psychiatry 2003;57(3):227–32, and Wassermann and Lisanby, Clin Neurophysiol 2001; 112(8):1367–77), and a recent meta-analysis of selected studies found only minimal evidence of efficacy (Martin et al, Br J Psychiatry 2003;182:480–91). Factors that may have contributed to these inconsistent results include small samples and other design shortcomings in most studies, the inclusion of subjects with refractory depression, varying stimulus parameters and uncertainty about the precise cortical areas to be targeted. Clearly, much more work must be done to establish rTMS as a routine treatment for depression, but it is one option for patients with refractory depression.

The comparison of rTMS to ECT is intriguing because both involve the induction of electrical activity in the brain, and rTMS may also produce behavioural and gene expression effects similar to ECT in animals (Hasey, Can J Psychiatry 2001;46:720–7). Although several groups have reported comparable efficacy between rTMS and ECT, these reports have involved small samples, no placebo/sham-treated arm and low statistical power to detect differences. One group found ECT superior to rTMS in patients with psychotic depression (Grunhaus et al, Biol Psychiatry 2000;47:314–24.), and another found ECT superior on 1 of 2 outcome measures (Pridmore et al, Int J Neuropsychopharm 2000;3:129–34).

The effects of rTMS on cognition appear to be slight (Wassermann, Depress Anxiety 2000;12:124–9) and can include mild and transient improvements as well as impairments in specific areas of cognition. In a recent study directly comparing ECT with rTMS, ECT was more effective in alleviating depression but produced more obvious (albeit mostly short-lived) deficiencies in various components of memory (O’Connor et al, Cogn Behav Neurol 2003;16(2):118–27). rTMS also avoids the risks and expenses involved in managing the grand mal seizures induced by ECT.

Thus, although the efficacy of rTMS is still not firmly established, it offers potential advantages over ECT in the areas of safety and side-effects and may be worth pursuing in individual cases. Legal status and availability of rTMS may vary among jurisdictions, and clinicians should comply with regulations and guidelines appropriate to their location.

Footnotes

  • To submit questions for this regular feature, please send them to the Journal of Psychiatry & Neuroscience / Revue de psychiatrie & de neuroscience, Canadian Medical Association, 1867 Alta Vista Dr., Ottawa ON K1G 3Y6, Canada; fax 613 729-9545; jpn.office{at}sympatico.ca. Please include details of any relevant case and your name, address, telephone and fax numbers as well as your email address.

  • The information in this column is not intended as a definitive treatment strategy but as a suggested approach for clinicians treating patients with similar histories. Individual cases may vary and should be evaluated carefully before treatment is provided.

  • Competing interests: None declared.

PreviousNext
Back to top

In this issue

Journal of Psychiatry and Neuroscience: 28 (5)
J Psychiatry Neurosci
Vol. 28, Issue 5
1 Sep 2003
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on JPN.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Repetitive transcranial magnetic stimulation for depression
(Your Name) has sent you a message from JPN
(Your Name) thought you would like to see the JPN web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Repetitive transcranial magnetic stimulation for depression
Robert G. Cooke
J Psychiatry Neurosci Sep 2003, 28 (5) 400;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Repetitive transcranial magnetic stimulation for depression
Robert G. Cooke
J Psychiatry Neurosci Sep 2003, 28 (5) 400;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Submit a manuscript
  • Manuscript Submission Checklist

About

  • General Information
  • Staff
  • Editorial Board
  • Contact Us
  • Advertising
  • Reprints
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. Print ISSN 1180-4882; Online ISSN 1488-2434.

All editorial matter in JPN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.
To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].

CMA Civility, Accessibility, Privacy

 

Powered by HighWire